At Visikol, our services have grown from our expertise in cell culture, high-content tissue imaging, and advanced digital pathology. [...]
About Griffin FerraraThis author has not yet filled in any details.
So far Griffin Ferrara has created 38 blog entries.
The immune system can be broken down into two main parts: innate and adaptive responses. An innate immune response [...]
Light sheet fluorescence microscopy (LSFM) is a powerful tool in the life science researcher’s toolkit. While the old histopathology [...]
Drug discovery is the process by which potential new medicines are identified, repurposed and/or designed. This involves a wide [...]
Highlights 3D liver fibrosis models typically incorporate both hepatocytes and various non-parenchymal (NPC) populations. Stimulation of these models [...]
Hampton, NJ – March 9th, 2021 – Visikol today announced its partnership with Bruker to use Bruker’s flagship MuVi [...]
Visikol was originally founded as a products oriented company when it launched its Visikol® HISTO™ portfolio of reagents and [...]
Pharma Tech Outlook acknowledges Visikol and how the company is leveraging its advanced imaging and 3D cell culture solutions [...]
After completing the imaging process for your desired biological model, you may find that some of your images have [...]
Visikol CEO Dr. Michael Johnson will be hosting a webinar with Leica Biosystems discussing multiplex imaging and the Leica [...]